Improving outcomes through maintenance therapy in AML: Incorporating the patient voice into long-term management strategies 
This survey is provided by Haymarket Medical Education (HME) in partnership with KNOW AML, and it is supported by an educational grant from Bristol Myers Squibb.

As someone who has been diagnosed with acute myeloid leukemia (AML), your open and honest input is important.
This survey will take approximately 10-15 minutes to be completed. The questionnaire is about your diagnosis, care, and treatment for AML.

 Participation in this survey is entirely voluntary. We are committed to protecting the personal data of all participants. To learn more about how we process your personal data, read the HME privacy notice here and the Scientific Education Support privacy notice here. All information collected in this survey is anonymous.

 Note: This is a global survey. As the survey is provided by Haymarket Medical Education, a US-based institution, US spelling is used throughout.

Question Title

* 1. To begin the survey, please provide consent below.